DOI:
10.1055/s-00032260
Digestive Disease Interventions
LinksClose Window
References
Floudas CS, Brar G, Mabry-Hrones D. et al.
A pilot study of the PD-1 targeting agent AMP-224 used with low-dose cyclophosphamide and stereotactic body radiation therapy in patients with metastatic colorectal cancer.
Clin Colorectal Cancer 2019;
18 (04) e349-e360
We do not assume any responsibility for the contents of the web pages of other providers.